603262.SH
TSI Group Co., Ltd.
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 15.49
+2.11%Year over year
Reported trailing growth
- Revenue
- +2.7%
- EBITDA
- —
- EBIT
- -36.3%
- EPS
- -37.8%
- Free cash flow
- —
- Operating cash flow
- -16.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.9%
- EBITDA
- -1.6%
- EBIT
- -4.3%
- Net income
- -2.0%
- EPS
- -4.2%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026